Kumuda Company

A new approach to drug discovery

Investors

Technology: Immunotherapy
Industry: Early Drug Development, PharmTech
Headquarters: Boston, Massachusetts, United States
Founded Date: 2020-01-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 1
Total Funding: 120000
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-01-17
Last Funding Type: Pre-Seed

Visit Website
team@kumudarx.com
https://twitter.com/KumudaRx
Register and Claim Ownership